Drug intelligence / Profile preview

ruscus extract + hesperidin methyl chalcone + ascorbic acid

Development stage
Phase 2
Lead developer
Pierre Fabre
Modality
Small Molecules
Administration
Oral
01

Overview

Ruscus extract + hesperidin methyl chalcone + ascorbic acid is a fixed-dose combination therapy used primarily as a venotonic and vasculoprotective agent for the treatment of chronic venous disease (CVD) and hemorrhoidal symptoms. Developed by Pierre Fabre Laboratories, the formulation leverages three synergistic components: **Ruscus extract** (from *Ruscus aculeatus*), which contains ruscogenins that act as agonists at post-junctional alpha-1 and alpha-2 adrenergic receptors on venous smooth muscle cells to increase venous tone; **hesperidin methyl chalcone**, a flavonoid that reduces capillary permeability and improves microcirculation; and **ascorbic acid** (Vitamin C), which serves as a cofactor for collagen synthesis, thereby enhancing capillary resistance and protecting vascular endothelium from oxidative stress. The combination is indicated for the relief of symptoms associated with venous-lymphatic insufficiency, such as heavy legs, pain, and nocturnal cramps.

Brand names
Cyclo 3 FortCyclo3 FortCyclo-3 FortCyclo 3Cyclo3Cyclo-3
Other names
Ruscus aculeatus extract + hesperidin methyl chalcone + ascorbic acidRuscus aculeatus extract + hesperidin methylchalcone + vitamin CRuscus extract/hesperidin methyl chalcone/ascorbic acid
02

Targets

ADRA1A (α1A)

Beyond the preview

Go deeper on ruscus extract + hesperidin methyl chalcone + ascorbic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ruscus extract + hesperidin methyl chalcone + ascorbic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call